Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates

被引:4
|
作者
Capel, Elena [1 ]
Parera, Mariona [1 ]
Clotet, Bonaventura [1 ]
Angel Martinez, Miguel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Badalona 08916, Spain
关键词
HIV; Integrase; Diversification; Fitness; IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 CELL COUNTS; DRUG SUSCEPTIBILITY; ELITE CONTROLLERS; RESISTANT HIV-1; FITNESS; PROTEASE; GAG; VIRULENCE; EVOLUTION;
D O I
10.1016/j.virol.2013.06.023
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During the human immunodeficiency virus type 1 (HIV-1) pandemic, continuous, extensive genetic diversification of the virus has been observed. To study the effect of HIV-1 diversification on integrase-associated viral replication capacity (RC), 94 HIV-1 subtype B integrase sequences from two groups of antiretroviral-naive viruses isolated 15 y apart were amplified and recombined with an HIV-1 infectious clone. Viral RC was determined by infecting a T cell line with a long terminal repeat-driven green fluorescent protein reporter. Significant differences in integrase-mediated RC were observed between recombinant viruses from early and late isolates (p = 0.0286). Integrases from late isolates had significantly lower sequence conservation scores compared to an ancestral subtype B sequence (p < 0.0001). Integrase amino acid polymorphisms S17N, I72V, S119P, and D256E were associated with a lower ex vivo viral RC. These results suggest that integrase sequence diversification has affected ex vivo HIV-1 RC. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:274 / 281
页数:8
相关论文
共 50 条
  • [21] Replication Capacity of HIV-1 in the Presence of Resistance-Associated Substitutions in Protease
    Winslow, Dean L.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (01) : 165 - 166
  • [22] GCN2 phosphorylates HIV-1 integrase and decreases HIV-1 replication by limiting viral integration
    Jaspart, A.
    Calmels, C.
    Cosnefroy, O.
    Bellecave, P.
    Pinson, P.
    Claverol, S.
    Guyonnet-Duperat, V.
    Dartigues, B.
    Benleulmi, M. S.
    Mauro, E.
    Gretteau, P. A.
    Parissi, V.
    Metifiot, M.
    Andreola, M. L.
    SCIENTIFIC REPORTS, 2017, 7
  • [23] HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection
    Winston, JA
    Klotman, ME
    Klotman, PE
    KIDNEY INTERNATIONAL, 1999, 55 (03) : 1036 - 1040
  • [24] GCN2 phosphorylates HIV-1 integrase and decreases HIV-1 replication by limiting viral integration
    A. Jaspart
    C. Calmels
    O. Cosnefroy
    P. Bellecave
    P. Pinson
    S. Claverol
    V. Guyonnet-Dupérat
    B. Dartigues
    M. S. Benleulmi
    E. Mauro
    P. A. Gretteau
    V. Parissi
    M. Métifiot
    M. L. Andreola
    Scientific Reports, 7
  • [25] Inhibition of replication of HIV-1 at both early and late stages of the viral life cycle by single-chain antibody against viral integrase
    Kitamura, Y
    Ishikawa, T
    Okui, N
    Kobayashi, N
    Kanda, T
    Shimada, T
    Miyake, K
    Yoshiike, K
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (02) : 105 - 114
  • [26] HIV-1 integrase: Structural organization, conformational changes, and catalysis
    Asante-Appiah, E
    Skalka, AM
    ADVANCES IN VIRUS RESEARCH, VOL 52, 1999, 52 : 351 - 369
  • [27] HIV-1 replication capacity: Setting the pace of disease
    Williamson, Carolyn
    Swanstrom, Ronald
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (12) : 3591 - 3592
  • [28] Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance
    Lataillade, M.
    Chiarella, J.
    Kozal, M. J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S28 - S28
  • [29] Styrylquinoline derivatives:: A new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells
    Mekouar, K
    Mouscadet, JF
    Desmaële, D
    Subra, F
    Leh, H
    Savouré, D
    Auclair, C
    d'Angelo, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) : 2846 - 2857
  • [30] Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance
    Lataillade, Max
    Chiarella, Jennifer
    Kozal, Michael J.
    ANTIVIRAL THERAPY, 2007, 12 (04) : 563 - 570